Published in Neurology on June 20, 2007
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke (2009) 3.23
Sex differences in stroke. J Cereb Blood Flow Metab (2012) 1.21
Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging (2008) 1.20
The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J Neurosci (2010) 1.18
Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol (2012) 1.10
Stroke in women: disparities and outcomes. Curr Cardiol Rep (2010) 1.07
Sexual dimorphism in ischemic stroke: lessons from the laboratory. Womens Health (Lond Engl) (2011) 1.00
Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99
Sex-specific responses to stroke. Future Neurol (2010) 0.96
Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int (2012) 0.96
Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms. Thrombosis (2011) 0.94
Perception of risk and knowledge of risk factors in women at high risk for stroke. Stroke (2009) 0.94
Stroke in women: risk and prevention throughout the lifespan. Neurol Clin (2008) 0.91
Cardiovascular diseases in American women. Nutr Metab Cardiovasc Dis (2010) 0.90
Age-related changes in brain support cells: Implications for stroke severity. Neurochem Int (2013) 0.89
Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One (2014) 0.88
PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol (2013) 0.87
Female gender remains an independent risk factor for poor outcome after acute nontraumatic intracerebral hemorrhage. Neurol Res Int (2013) 0.85
Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging (2011) 0.84
Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging. Neurobiol Dis (2015) 0.82
Non-feminizing estrogens: a novel neuroprotective therapy. Mol Cell Endocrinol (2014) 0.81
Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke. Horm Behav (2012) 0.81
Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats. Brain Res (2012) 0.81
Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmol (2012) 0.81
Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study. Front Neuroendocrinol (2014) 0.80
Sex and stroke: are they really different in midlife? Neurology (2007) 0.79
Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats. Endocrinology (2015) 0.78
Stroke prevention in women: challenges and opportunities. Curr Atheroscler Rep (2008) 0.77
Effects of Estrogen and Phytoestrogen Treatment on an In Vitro Model of Recurrent Stroke on HT22 Neuronal Cell Line. Cell Mol Neurobiol (2016) 0.77
Risk factors of transient ischemic attack: An overview. J Midlife Health (2016) 0.76
Redistribution of NMDA Receptors in Estrogen-Receptor-β-Containing Paraventricular Hypothalamic Neurons following Slow-Pressor Angiotensin II Hypertension in Female Mice with Accelerated Ovarian Failure. Neuroendocrinology (2016) 0.75
Microglia and Monocyte-Derived Macrophages in Stroke. Neurotherapeutics (2016) 0.75
Inhibition of miR-181a protects female mice from transient focal cerebral ischemia by targeting astrocyte estrogen receptor-α. Mol Cell Neurosci (2017) 0.75
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med (2009) 3.07
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
The smoking-thrombolysis paradox and acute ischemic stroke. Neurology (2005) 2.31
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci (2008) 2.25
Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke (2011) 2.23
Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke (2010) 2.17
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06
Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ (2012) 2.04
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke (2014) 1.98
Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke (2009) 1.96
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke (2014) 1.76
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71
Expanding indications for statins in cerebral ischemia: a quantitative study. Arch Neurol (2005) 1.69
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation (2010) 1.66
Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke (2009) 1.63
Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis (2003) 1.60
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59
Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver disease. Liver Transpl (2006) 1.58
Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med (2012) 1.55
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes (2012) 1.54
Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54
Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol (2007) 1.53
Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation (2011) 1.51
Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc (2012) 1.48
Does achieving an intensive versus usual blood pressure level prevent stroke? Ann Neurol (2011) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Risk of intracranial hemorrhage with protease-activated receptor-1 antagonists. Stroke (2012) 1.44
Prevention and management of stroke in very elderly patients. Lancet Neurol (2009) 1.43
Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke (2012) 1.43
The new standing guideline committee policy of the American Stroke Association Stroke Council. Stroke (2006) 1.42
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke (2012) 1.41
Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke (2010) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke (2012) 1.40
Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40
Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke (2009) 1.38
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis (2008) 1.37
Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke (2005) 1.37
Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis (2008) 1.37
Evidence of publication bias in reporting acute stroke clinical trials. Neurology (2006) 1.37